Market reports, free public health charts and stories on biologics and biosimilars, across every category we cover.
Our markets on biologics and biosimilars, by category.
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Worldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View reportNamed as key players in the most of these markets.
Novartis AG3 markets here
Amgen Inc.2 markets here
B. Braun Melsungen AG2 markets here
Pfizer Inc.2 markets here
AbbVie Inc.1 market here
Allergan (a subsidiary of AbbVie)1 market here
Americord1 market here
Anika Therapeutics, Inc1 market here
Arthrex, Inc.1 market here
Asahi Kasei Medical Co., Ltd.1 market here
Aspire Medical Innovation1 market here
Biocon Limited1 market here
Each opens the market's statistics page, with every country we cover.
Medical Devices
Pharmaceuticals
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.